EyePoint Pharmaceuticals
EYPT
#10568
Rank
HK$0.27 B
Marketcap
HK$3.17
Share price
-5.51%
Change (1 day)
-96.63%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -HK$2.39 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are HK$2.78 Million. In 2025 the company made an earning of -HK$1.82 Billion a decrease over its 2024 earnings that were of -HK$1.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$2.39 Billion31.3%
2025 -HK$1.82 Billion63.24%
2024 -HK$1.12 Billion104.29%
2023 -HK$0.55 Billion-29.88%
2022 -HK$0.78 Billion87.2%
2021 -HK$0.42 Billion38.58%
2020 -HK$0.3 Billion-24.56%
2019 -HK$0.4 Billion
2017 -HK$0.19 Billion22.59%
2016 -HK$0.15 Billion-8.02%
2015 -HK$0.17 Billion-296.09%
2014 HK$81.89 M-174.02%
2013 -HK$0.12 Billion37.42%
2012 -HK$80.51 Million-56.29%
2011 -HK$0.19 Billion-1062.38%
2010 HK$19.13 M-250.43%
2009 -HK$12.73 Million-89.5%
2008 -HK$0.13 Billion
2005 -HK$74.74 Million56.99%
2004 -HK$47.61 Million73.7%
2003 -HK$27.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$16.96 Million-99.29% Bahamas
NRC Health
NRC
HK$0.11 B-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA